US HB3248 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 11 2023 - 25% progression
Action: 2023-05-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 11 2023 - 25% progression
Action: 2023-05-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XVIII of the Social Security Act to increase price transparency of clinical diagnostic laboratory tests under the Medicare program.
Title
Diagnostic Lab Testing Transparency Act
Sponsors
| Rep. Mariannette Miller-Meeks [R-IA] | Rep. Diana DeGette [D-CO] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-05-12 | House | Referred to the Subcommittee on Health. |
| 2023-05-11 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2023-05-11 | House | Introduced in House |
Same As/Similar To
HB3561 (Related) 2023-05-24 - Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/3248/all-info |
| Text | https://www.congress.gov/118/bills/hr3248/BILLS-118hr3248ih.pdf |
